Chemoinformaics analysis of 1-Ethyl-2,3-dimethylbenzene
| Molecular Weight | 134.222 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 6 |
| Exact Molecular Weight | 134.11 | nRing | 1 |
| Solubility: LogS | -3.996 | nHRing | 0 |
| Solubility: LogP | 4.069 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 26.0351 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.554 |
| Synth | 1.598 |
| Natural Product Likeliness | -0.814 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.025 |
| HIA | 0.004 |
| CACO-2 | -4.349 |
| MDCK | 0.0000246 |
| BBB | 0.879 |
| PPB | 0.939055 |
| VDSS | 2.076 |
| FU | 0.0568265 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.943 |
| CYP2c19-inh | 0.691 |
| CYP2c19-sub | 0.836 |
| CYP2c9-inh | 0.348 |
| CYP2c9-sub | 0.729 |
| CYP2d6-inh | 0.564 |
| CYP2d6-sub | 0.908 |
| CYP3a4-inh | 0.216 |
| CYP3a4-sub | 0.426 |
| CL | 10.878 |
| T12 | 0.407 |
| hERG | 0.025 |
| Ames | 0.07 |
| ROA | 0.018 |
| SkinSen | 0.268 |
| Carcinogencity | 0.431 |
| EI | 0.996 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.916617 |